EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 29 filers reported holding EVOKE PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 259,100 | $1,355,000 | 0.54% |
| Knoll Capital Management, LLC | 55,660 | $291,000 | 0.09% |
| Financial Architects, Inc | 2,150 | $11,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,396 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,864 | $82,000 | 0.00% |
| BlackRock Investment Management, LLC | 489 | $3,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,062 | $5,000 | 0.00% |
| MORGAN STANLEY | 1,661 | $9,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 36,700 | $192,000 | 0.00% |
| Renaissance Technologies | 13,024 | $68,000 | 0.00% |